AttoQuest was founded by Professors Yann Gambin and Emma Sierecki whose innovative work primarily focuses on advancing scientific research in the field of molecular biology, biophysics, and drug discovery using advanced imaging technologies. Their work revolves around developing cutting-edge techniques to visualise and study proteins and other biomolecules at the single-molecule level, which is critical in understanding biological mechanisms in greater detail.
The single-molecule approach has profound implications for drug development, disease diagnostics, and therapeutic interventions. By leveraging their academic expertise and UNSW’s current resources, AttoQuest Life Sciences aims to bridge the gap between academic research and real-world applications in life sciences, particularly in areas like personalised medicine and targeted therapies.
